Print Page | Close Page

 
 

BD Medical Pharmaceutical Systems

Address: 11 Rue Aristide Berges, Le Pont-De-Claix, F-38800
 
Country: France
 
Parent: Becton Dickinson
 
Sectors: Proprietary Research & Manufacture, Collaborations & Partnerships- R&D, Contract Research & Development, Contract Manufacturing, Collaborations & Partnerships-Manufacture, Medical Devices, Drug Delivery
 
Telephone: +33 476 68 36 36
 
Website: http://www.bd.com/pharmaceuticals
 
- - -
 

About Us

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes. 

The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 65,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.

 
- - -
 

Sectors

  • Proprietary Research & Manufacture
  • Collaborations & Partnerships- R&D
  • Contract Research & Development
  • Contract Manufacturing
 
  • Collaborations & Partnerships-Manufacture
  • Medical Devices
  • Drug Delivery
 
- - -
 

Categories

  • Medical Devices
  • Drug Delivery Technology
  • Combination Products
  • Sterile Formulations
  • Syringe Filling
  • Self-Injection Devices
  • Injectables
 
  • Auto Injectors
  • Pre-filled Syringes
  • Pens-auto injection
  • Needle-free Jet Injectors
  • Pens-Insulin
  • Hospital Products
 
- - -
 

News

 
04th November 2016
 

BD injects $100m into Nebraska insulin syringe plant

 
Becton Dickinson says it is upgrading equipment and technology at its Holdrege manufacturing facility to better serve the global diabetes market.
 
- - -
 
Printed: 10-Jun-2026 at 16:40:41 hrs
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com